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1. Introduction 
12-O-tetradecanoyl-phorbol-13-acetate (TPA) 
which was isolated from croton oil [l] together with 
several other diesters of the tetracyclic diterpene 
phorbol, has emerged as the most potent tumor 
promoter. The tumor-promoting activity of TPA is 
related to its ability to enhance the expression of the 
tumor phenotype in mouse skin [2,3], in virally- 
transformed cells [4,5] as well as in various types of 
cultured cells pre-treated with chemical or physical 
carcinogenic agents [6-91. 
The cell membrane is generally considered to be 
the target site for the tumor promoter which is 
known to cause alterations in several membrane- 
associated processes. TPA alters ion fluxes [lo], 
decreases (Na+, K’) and (Mg”, Ca2’) ATPase activities 
[ 111, induces specific changes of adenylate and 
guanylate cyclase activities [ 121, modifies glucose 
uptake [ 131 and cell permeability to trypan blue 
[ 141. In addition, TPA has been shown to alter the 
protein composition of the outer side of the mem- 
brane [ 1.51; TPA has been shown to induce surface 
structural changes in the surface of lymphoblastoid 
cells and to cause adhesion of cells to the sub- 
stratum [ 161. 
The fluidity of the lipid matrix regulates the 
dynamic state of the cell membrane. It influences 
lateral diffusion and rotation of membrane proteins 
[ 171, controls their degree of exposure [ 181 and 
modulates the activities of membrane-bound enzymes 
[ 19,201. These observations suggested that TPA could 
affect the fluidity of the lipid core of the cell mem- 
branes. The biological lipid complex can be 
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quantitatively monitored by fluorescence polariza- 
tion analysis with the aid of the fluorescent hydro- 
carbon probe 1,6-diphenyl 1,3,5_hexatriene (DPH) 
[2 11. From the recorded degree of fluorescence 
polarization, the degree of microviscosity of the 
analyzed sample can be estimated [22]. 
To study the effect of TPA on the degree of micro- 
viscosity, the response of several ymphoblastoid cells 
lines to treatment with the tumor promoter was 
investigated. For purposes of comparison, the effect 
of 4-0methyl-phorbol 12, 13-didecanoate (MePDD), 
a TPA derivative, which is inactive as tumor promoter, 
was also examined. We report here a decrease in the 
degree of lipid microviscosity in all cell lines exhibiting 
altered adhesion properties in response to TPA treat- 
ment. These alterations were accompanied by a 
marked stimulation of cholesterol and phospholipid 
metabolism. 
2. Materials and methods 
Murine (L12 10 line) and human lymphoblastoid 
cell lines from normal (LHN 13) and malignant origin 
(Namalwa, Raji, Reh 6) were used. Cells were treated 
with phorbol esters or acetone (phorbol ester, solvent), 
12 h after plating, and collected at the following 
times: the cells in suspension were withdrawn with 
the culture medium and the cells which had adhered 
to the plastic dish were detached with trypsin (3 min 
incubation at 37°C in PBS containing 0.06% trypsin 
plus 0.1% EDTA) before being centrifuged at 
400 X g for 10 min and resuspended in phosphate- 
buffered saline (PBS) containing 30 pg/ml of soy bean 
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trypsin inhibitor. Pooled suspended plus attached cells 
were pelleted at 400 X g for 10 min and resuspended 
in PBS. The cells were washed twice before undergoing 
fluorescence measurements and biochemical deter- 
minations. The two cell populations were kept apart 
and washed separately in order to either compare the 
lipid microviscosity of suspended cells to that of 
attached cells or to carry out the attachment assay 
[ 161. Care was taken that trypsin treatment did not 
affect the fluorescence measurements. 
Lymphocytes were isolated from blood obtained 
from healthy donors by Ficoll-hypaque gradient 
centrifugation [23]. T lymphocytes were isolated 
from thymus obtained from myasthenic patients by 
gently pressing and filtration through multiple layers 
of cheese-cloth: the cell suspension contained > 95% 
of lymphocytes as shown by microscope examination. 
Lymphoblasts were isolated from the peripheral 
blood of leukemic patients in clinical relapse, as in 
[23]. T and B lymphocytes and leukaemic cells were 
seeded at 3 X lo6 cells/ml in RPM1 medium 1640 
(Gibco Paisley, Scotland) containing 20% fetal calf 
serum before being treated by phorbol esters under 
conditions similar to those used for cell lines. 
Liposomes were prepared from the whole cells 
as in [24]. 
The fluorescence measurements were conducted 
as in [25]. The cells were labelled with DPH by 
incubation for 30 min at 25°C with 3 ml 2 ,uM DPH 
dispersed in PBS. The fluorescent labelled samples 
were subjected to fluorescence polarization analysis 
with an Elscint microviscosimeter. From the recorded 
p values, the degree of microviscosity was calculated 
as in [26]. 
Lipid was extracted from the whole cells pre- 
labelled with both DL [2-3H] mevalonic acid lactone 
obtained from the Radiochemical Centre (Amersham) 
and [32P] phosphoric acid from CEA(Saclay). Extracts 
were then assayed for total cholesterol [27], total 
phospholipids [28] and counted for 3H and 32P 
radioactivities using an intertechnique spectrometer. 
Phorbol esters were purchased from Consolidated 
Midland Co. 
3. Results 
TPA decreased the lipid microviscosity of various 
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Fig.1. Namalwa cells 6 X lO’/ml were re-fed with RPM1 
medium 1640 supplemented with 20% fetal calf serum. 
Cells were treated 12 h after seeding with various amounts 
of TPA (o-0) or MePDD (o-o) and underwent fluorescence 
measurements 2 h later. Control cultures were treated with 
the same volume of acetone (phorbol ester solvent) as that 
added to cells treated with phorbol esters (usually 1 wl/ml 
medium). Acetone did not impair either cell proliferation or 
fluorescence measurements. The values were means of two 
individual experiments. 
Table 1 
Fluorescence polarization p and lipid microviscosity S at 25°C 
of liposomes prepared from phorbol treated LHN 13 cells 
P 
s 
Acetone TPA MePDD 
0.228 0.202 0.222 
2.11 1.62 1.98 
Accuracy of fluorescence polarization measurement p is 
i 0.005 
LHN 13 line was subcultured by refeeding with RPM1 
medium 1640 supplemented with 10% calf serum at 
5 X lo5 cells/ml. Cells were treated with phorbol esters at 
100 ng/ml and liposomes prepared as in section 2 24 h later. 
The procedure to measure fluorescence polarization in lipo- 
somes was as in the text for the whole cells at various times 
after the start of the treatment. Figures represent mean of 
two experiments Yj is expressed in poises 
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lymphoblastoid cell lines. The effect observed in 
Namalwa cells lines is shown in fig.1. The effect of 
TPA on microviscosity occurred rapidly, was dose- 
dependent and was detectable at a concentration of 
1 &ml. The cells appeared to be about IOO-fold less 
sensitive to MePDD, the inactive derivative of TPA. 
The TPA-mediated alterations of microviscosity were 
also observed when liposomes prepared from the 
whole cells were subjected to fluorescence polariza- 
tion analysis and the effect was observed over the 
3 day period of the experiment, as illustrated in table 1. 
A number of lymphoblastoid cell lines from 
human and murine origin as well as thymus and 
peripheral blood lymphocytes were examined for the 
effects of phorbol esters on lipid microviscosity deter- 
mined by the measurements of fluorescence polariza- 
tion. The results reported in table 2, showed that B 
lymphocytes and 3 out of 5 cell lines exhibited a 
decreased lipid microviscosity as demonstrated by an 
increase in fluorescence polarization. The results, 
reported in table 2, showed that B lymphocytes and 
3 out of 5 cell lines exhibited a decreased lipid 
microviscosity after exposure to TPA, whereas MePDD 
was not significantly effective upon any of them. 
It should be pointed out that those cells which 
responded to TPA treatment by a decrease of lipid 
microviscosity also exhibited altered adhesive proper- 
ties and yielded a positive response to the attachment 
assay [ 161. These data suggested that the lipid micro- 
viscosity of suspended and attached cell populations 
might be affected differently. In order to investigate 
this possibility three responsive cell lines were tested: 
LHNl3, Namalwa and Reh 6. The results revealed that 
a decrease of lipid microviscosity was observed in the 
attached cells whereas that of cells growing in suspen- 
sion was unaffected or slightly increased (table 3). 
The unresponsive lymphoblastoid cell lines such as 
Raji or L1210 lines neither attached to the culture 
dish, nor exhibited a decrease of membrane micro- 
viscosity regardless of the TPA concentration and the 
time of the fluorescence polarization measurements. 
Lipid microviscosity was generally unaffected or 
slowly increased (data not shown). Since a slight 
increase of microviscosity occurred in aged cultures 
it was suggested that this increase of microviscosity 
may be due to the inhibition of growth which was 
generally observed in lymphoblastoid cell in response 
to TPA [16]. 
Table 2 
























Human acute lympho- 
blastic leukemia 









2.76 1.62 t 
2.88 2.31 _ + 
2.17 2.06 2.11 _ 
2.48 2.0 2.38 + 
1.74 1.82 _ _ 
2.61 2.17 2.50 + 
1.86 1.90 1.90 _ 
2.06 1.72 2.13 t 
Lymphocytes were obtained as in section 2. The culture conditions for LHN 13 and Namalwa lines were as in table 1 and fig.1. 
The three other cell lines were cultivated in RPM1 medium 1640 supplemented with either 20% horse serum (L1210), 202 fetal 
calf serum (Raji) or 10% calf serum (Reh 6). Cells were treated with 30 ng/ml phorbol esters and analyzed for fluorescence polari- 
zation 6 h later. Figures are means of 2-6 reproducible experiments 
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Table 3 
Differential effects of TPA on lipid microviscosity 17 of suspended and substrate-attached lymphoblastoid cells 
Cell lines 
\ 
LHN 13 Namalwa Reh 6 
Treatment\ Suspension Attached Suspension Attached Suspension Attached 
Acetone 2.56 2.56 2.52 2.52 2.10 2.10 
TPA 2.63 1.83 2.61 1.98 2.14 1.64 
~~ 
7 was expressed in poises 
The three cell lines were treated with TPA at 100 ng/ml TPA. Then attached and suspension type cells were separately examined 
for fluorescence polarization 24 h later. Figures are means of 2 or 3 reproducible experiments 
Some experiments have been carried out in order 
to determine whether the observed effect of TPA on 
membrane microviscosity was associated with altera- 
tions of the main lipid components which are known 
to influence lipid microviscosity [29]. The metab- 
olism and cellular content of cholesterol and phos- 
pholipid were examined within 24 h after the addi- 
tion of phorbol esters. Both phospholipid and 
cholesterol synthesis were markedly stimulated from 
6 h after the start of treatment with the tumor 
promoter. The inactive TPA derivative caused a much 
lesser effect on phospholipid and cholesterol synthesis. 
The cholesterol to phospholipid molar ratio was 
slightly lower than that of controls (table 4). 
4. Discussion 
A small but significant effect of TPA on the native 
fluorescence of membrane protein has been reported 
[30] suggesting that the tumour promoter may affect 
structural and dynamic properties of the cell mem- 
branes. The present experiments show a decrease in 
the degree of lipid microviscosity of human lympho- 
cytes and lymphoblastoid cells in response to TPA 
and provide further evidence for such alterations. 
The effect of TPA on the degree of fluidity of the 
cell membrane occurred rapidly and was associated 
with surface structural changes and altered adhesion 
properties [ 161 . The decreased microviscosity was 
observed in several cell lines but some of them 
appeared to be unresponsive in regard to lipid micro- 
viscosity as well as adhesion effect. 
The decreased microviscosity of the lipid mem- 
brane was found to be associated with a marked 
stimulation of both cholesterol and phospholipid 
metabolism. Such a TPA-mediated activation of 
phospholipid synthesis has been described [3 l] in 
Table 4 
Phorbol ester-induced alterations in cholesterol and phospholipid metabolism 
Cholesterol : phospholipid Spec. act. cholesterol 
(mol/mol) (dpm/pg) 
Spec. act. phospholipid 
(dpm/pg phospholipid-phosphate) 
treatment 
Acetone TPA MePDD Acetone TPA MePDD Acetone TPA MePDD 
6h 0.52 0.49 0.51 27.7 k 5.1 58.1 t 12.8 15.7 f 6.4 886 f 40 1451 + 52 695 f 25 
24 h 0.57 0.48 - 19.1 + 4.6 123 f 24 - 55Ok19 1977?61 526+12 
LHN 13 cells, which were phorbol ester-treated 12 h after plating and received, simultaneously, 2.5 @X/ml [3ZP]phosphoric acid 
(2 Ci/mg) and 3 Ki/ml [ 3H]mevalonic acid lactone (168 Ci/mol), 4 h later. Over a 2 h period the cells were incubated then 
harvested before undergoing biochemical determinations. Lipids were extracted from the pooled suspended plus attached cells. 
For experimental details see text 
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mouse skin and the effect suggested to result in the 
initiation of cell proliferation observed in such a 
tissue after TPA treatment. The results presented 
here, which were obtained on growth-inhibited 
lymphoblastoid cells, favour the possibility that TPA 
specifically acts upon lipid metabolism. MePDD, a 
TPA derivative inactive as tumour promoter, was 
found to be much less effective, both on lipid 
metabolism and the fluidity of the lipid membrane, 
suggesting that these TPA-mediated alterations may 
be relevant to tumor promotion. 
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